A sophisticated buyer is one who understands risk and program structure, is transparent, and can have high-level conversations. This is how biotech industry insurance buyers were described by panelists on Advisen’s quarterly D&O Claims Trends webinar.
While it may sound more like a broker and underwriter dream than reality, it is one of the benefits of working with this challenging class, according to the panelists.
Read more at http://www.advisenltd.com/2015/07/22/the-biotech-industry-sophisticated-buyers-in-a-challenging-class/
Bradford, Josh. ‘The Biotech Industry: Sophisticated buyers in a challenging class’. ©2015 Advisen Ltd. 31 July 2015.
No comments:
Post a Comment